MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

Although specific microRNA (miRNA) signatures in classical Hodgkin lymphoma (cHL) have been proposed, their relationship with clinical outcome remains unclear. Despite treatment advances, a substantial subset of patients with advanced cHL are refractory to standard therapies based on adriamycin and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Haematol
Hlavní autoři: Sánchez-Espiridión, Beatriz, Martín-Moreno, Ana M., Montalbán, Carlos, Figueroa, Vianihuini, Vega, Francisco, Younes, Anas, Medeiros, L. Jeffrey, Alvés, Francisco J., Canales, Miguel, Estévez, Mónica, Menarguez, Javier, Sabín, Pilar, Ruiz-Marcellán, María C., Lopez, Andrés, Sánchez-Godoy, Pedro, Burgos, Fernando, Santonja, Carlos, López, José L., Piris, Miguel A., Garcia, Juan F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291117/
https://ncbi.nlm.nih.gov/pubmed/23725219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12390
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky